Welcome to the UPF Digital Repository

The expression of IL-17, in chronic spontaneous urticaria is linked to Semaphorin5A

Show simple item record

dc.contributor.author Matanis, Lobna
dc.contributor.author Eiza, Nasren
dc.contributor.author Sabag, Adi
dc.contributor.author Bejar, Jacob
dc.contributor.author Giménez Arnau, Anna Maria
dc.contributor.author Maurer, Marcus
dc.contributor.author Vadasz, Zahava
dc.date.accessioned 2021-09-01T06:47:01Z
dc.date.available 2021-09-01T06:47:01Z
dc.date.issued 2021
dc.identifier.citation Matanis L, Eiza N, Sabag A, Bejar J, Giménez-Arnau AM, Maurer M, Vadasz Z. The expression of IL-17, in chronic spontaneous urticaria is linked to Semaphorin5A. Biomolecules. 2021;11(3):373. DOI: 10.3390/biom11030373
dc.identifier.issn 2218-273X
dc.identifier.uri http://hdl.handle.net/10230/48357
dc.description.abstract Background: Patients with chronic spontaneous urticaria (CSU), an autoimmune disorder, show increased skin expression of IL-17A and can benefit from treatment with the anti-IL-17A biologic secukinumab. The mechanisms that drive IL-17A expression in CSU are currently unknown, but may involve Semaphorin5A (Sema5A). Objective: To explore the expression, role, and effects of Sema5A in CSU and its link to IL-17A. Material and Methods: We investigated patients with CSU and healthy controls for skin expression of expressing peripheral T cells. Results: Sema5A was highly expressed in the skin of CSU patients as compared to healthy control skin. Both CD4+ T cells and mast cells in CSU skin expressed Sema5A, and many of them expressed both Sema5A and IL-17A. Patients with CSU had significantly higher rates of IL-17A-expressing CD4+ T cells as compared to healthy controls. Incubation with Sema5A increased the rates of IL-17A-expressing CD4+ T cells in healthy controls to CSU levels. Conclusion: Sema5A may drive the expression and effects of IL-17A in CSU. Further studies in larger cohorts are needed to confirm the role of Sema5A in the pathogenesis of CSU and to explore its potential as a therapeutic target.
dc.format.mimetype application/pdf
dc.language.iso eng
dc.publisher MDPI
dc.relation.ispartof Biomolecules. 2021;11(3):373
dc.rights © 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
dc.rights.uri http://creativecommons.org/licenses/by/4.0/
dc.title The expression of IL-17, in chronic spontaneous urticaria is linked to Semaphorin5A
dc.type info:eu-repo/semantics/article
dc.identifier.doi http://dx.doi.org/10.3390/biom11030373
dc.subject.keyword IL-17
dc.subject.keyword T cells
dc.subject.keyword Chronic spontaneous urticaria
dc.subject.keyword Mast cells
dc.subject.keyword Semaphorin5A
dc.rights.accessRights info:eu-repo/semantics/openAccess
dc.type.version info:eu-repo/semantics/publishedVersion


This item appears in the following Collection(s)

Show simple item record

Search DSpace

Advanced Search


My Account


Compliant to Partaking